Registration

Igniting Innovation: Oracle Accelerates Research to Improve Patient Outcomes

The cost of bringing new therapies to market is rising and clinical trials are becoming increasingly complex. Discover how Oracle combines deep clinical expertise, unique data and cutting-edge technology to deliver consultative, end-to-end solutions that empower clinicians and improve the well-being of patients globally.

• Jeyaseelan Jeyaraj (Jey)

  Senior Director, Solutions Consulting, Asia Pacific
  Oracle Life Sciences

Technology - Key Value Driver in Scale-up for Pharma Global Capabilities Centre

The increasing trend in the biopharma Industry is to set up their global capabilities center in India. According to the E & Y report – Future of GCCs in India – June 2023 – GCCs across industries are expected to grow at a CAGR of 14% over the next eight years. For the Biopharma space, access to Talent, scaled-up and streamlined processes, and enabling technology tools are critical success factors.

• Dr. Chetan Tamhankar

  Vice President and Head, Clinical Development,
  Syngene International

Streamlining Clinical Research: The Power of Automated Data Flow

The range of available clinical trial data sources are more varied and complicated than ever, encompassing EHR, DCT, wearables, sensors, and more. Modern automation platforms are now essential, reducing cycle times and streamlining data management by automating end-to-end data flow. Discover the Transcelerate Digital Data Flow (DDF) initiative and how utilizing standards and digital protocol content can improve study setup and data flow automation.

• Jeyaseelan Jeyaraj (Jey)

  Senior Director, Solutions Consulting, Asia Pacific
  Oracle Life Sciences

Pharmacovigilance in Biosimilars

• Dr. Shubhadeep D. Sinha

  Senior Vice President & Global Head – CDMA
  (Clinical Development & Medical Affairs), Hetero

Unifying Clinical Development Process with Latest Technology

• Dr. Anand Eswaraiah

  Head – Global Clinical Operations, Dr. Reddy's Laboratories

The Art Of Simplifying Pharmacovigilance

In the intricate realm of pharmacovigilance, where a multitude of data points and signals weave together, lies the art of simplifying. It's a skill akin to that of an astute detective, meticulously examining evidence and unraveling complex webs of information. Like an artist, the pharmacovigilantist deftly joins the dots, connecting disparate data sources and spotting patterns that hold the key to patient safety. With each dot connected, a clearer picture emerges, illuminating potential risks and opportunities for preventive measures. It's a harmonious dance of data analysis and interpretation, where the virtuoso orchestrates a symphony of vigilance. Through this artistry, pharmacovigilance professionals ensure that every dot has its place, and the ultimate masterpiece is the safeguarding of public health.

• Dr. Vivek Ahuja

  SVP Global Delivery Excellence, Strategy & Growth (Pharmacovigilance, Quality and Regulatory),
  Eversana

Clinical One Analytics

Clinical One Analytics is a real-time, events-driven warehouse containing all the clinical and operational data available from Clinical One. Discover how clinical and operational data can be enriched and visualized with the highly stylized reports and dashboards of Clinical One Analytics. Use natural language and machine learning models to identify patterns, trends and make insightful commercial forecasts.

• Jeyaseelan Jeyaraj (Jey)

  Senior Director, Solutions Consulting, Asia Pacific
  Oracle Life Sciences

• Firasatullah Syed

  Principal Solutions Consultant, Oracle Life Sciences

Patient-Centred Approaches to Evidence Generation

Patient perspectives are now at the center of clinical drug development, care management, and healthcare decision-making. A systematic approach to collecting patient preferences is now needed to ensure that the evidence generated is robust and actionable. Discover how Oracle's innovative products and services can capture and process the precise patient data that meet stakeholder requirements. We present case studies from healthcare organizations using Oracle solutions to collect and use patient preferences to improve clinical trials, care delivery, and population health management.

• Neeyor Bose

  Associate Principal and Head
  Real World Evidence (Singapore)
  Oracle Life Sciences

Panel Discussion: Innovating through the use of real world data

Real-world data (RWD) plays an increasingly important role in clinical research, safety and healthcare decision making. In this panel session we will discuss how Real World data is enabling deeper understanding of disease behaviour and treatment responses across a wider patient population - Optimizing clinical study design and conduct, from both cost and timeline perspectives - Facilitating conduct of clinical trials on a more efficient timeline.

• Moderator: Jeyaseelan Jeyaraj (Jey)

  Senior Director, Solutions Consulting, Asia Pacific
  Oracle Life Sciences

• Dr. Anita Krishnan

  Head Global Operations, Novartis

• Dr. Rahul Kapur

  VP and Head - Medical Affairs, Patient Value and Innovation,
  Biocon Biologics

• Dr. Akash Gadgade

  Associate Director - Medical & Scientific Affairs,
  Navitas LifeSciences

• Rahul Nair

  Director & Head of Pharmacovigilance, Arco Lab

NextGen Safety One and Precision Pharmacovigilance

The Oracle Safety One platform provides interoperable business services using cloud-based A.I., enabling you to unify people, processes, and data throughout the entire lifecycle of your products. Find new ways to improve the safety of your medicinal products by combining real-world data sets containing anonymized, longitudinal records that expand the potential of safety signalling. Join us to find out about future applications leveraging advanced signal detection and safety case management with Real World Evidence (RWE) to achieve important healthcare outcomes.

• Firasatullah Syed

  Principal Solutions Consultant, Oracle Life Sciences

A Powerful Collaboration Focused on Driving Successful Outcomes

Hear about how Oracle collaborates with a range of organisations to realise their transformation goals throughout the clinical trial process. The journey includes co-innovation, business evaluations, established methods, empowerment, guidance, industry peer engagement, and professional services, delivering increased value from Oracle and our partner network.

• Dr. Sameer Thapar

  Global Head & Strategy, MultiVigilance Operations,
  Oracle Life Sciences

Networking